Close

Catyalyst Pharmaceutical Partners (CPRX) Tops Q2 EPS by 2c

August 14, 2014 8:04 AM EDT

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q2 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings